Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top

Seminars in Immunopathology

Issue 3/2014

B cell-mediated autoimmune diseases

Content (9 Articles)

Editorial

Introduction: B cell-mediated autoimmune diseases

Thomas H. Winkler, Reinhard E. Voll

Review

Plasma cells in immunopathology: concepts and therapeutic strategies

Benjamin Tiburzy, Upasana Kulkarni, Anja Erika Hauser, Melanie Abram, Rudolf Armin Manz

Review

Targeting B cells and autoantibodies in the therapy of autoimmune diseases

Daniela Kao, Anja Lux, Inessa Schwab, Falk Nimmerjahn

Review

The pathogenesis and diagnosis of systemic lupus erythematosus: still not resolved

Ole Petter Rekvig, Johan Van der Vlag

Review

The pathogenic potential of autoreactive antibodies in rheumatoid arthritis

Marieke Bax, Tom W. J. Huizinga, René E. M. Toes

Review

B cell-mediated pathogenesis of ANCA-mediated vasculitis

J. Charles Jennette, Ronald J. Falk

Review

B cells in MS and NMO: pathogenesis and therapy

Markus Krumbholz, Edgar Meinl

Review

Agonistic autoantibodies directed against G-protein-coupled receptors and their relationship to cardiovascular diseases

Gerd Wallukat, Ingolf Schimke

Review

Rationale for B cell targeting in SLE

Iñaki Sanz

Mar 14
Issue: 2/2014
New paradigms in leukocyte trafficking, lessons for therapeutics
Jul 14
Issue: 4/2014
Immunopathology of Glomerular Diseases

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits